This double-blind study randomized @ uncontrolled type @ diabetes patients ( HbA@c @ % and @ % ) , post @ months ' treatment with glimepiride/gliclazide and metformin , to additionally receive hydroxychloroquine @mg/day ( n = @ ) or pioglitazone @mg/day ( n = @ ) for @ weeks .